Northeast Investment Management Sells 582 Shares of The Clorox Company (NYSE:CLX)

Northeast Investment Management lessened its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 1.1% during the 4th quarter, Holdings Channel reports. The firm owned 54,224 shares of the company’s stock after selling 582 shares during the period. Northeast Investment Management’s holdings in Clorox were worth $8,807,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in shares of Clorox during the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC boosted its holdings in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the period. Carolina Wealth Advisors LLC purchased a new position in Clorox during the 3rd quarter valued at $48,000. Finally, Friedenthal Financial purchased a new position in Clorox during the 3rd quarter valued at $49,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $148.51 on Friday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a market cap of $18.38 billion, a price-to-earnings ratio of 40.58, a PEG ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The business’s 50 day moving average price is $161.06 and its 200 day moving average price is $158.70.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the firm posted $2.16 EPS. On average, research analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. Clorox’s dividend payout ratio is currently 133.33%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CLX. DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday. Barclays upped their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday. JPMorgan Chase & Co. upped their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $158.21.

Check Out Our Latest Stock Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.